Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry

Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry

Background: Hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling attacks. A European treatment registry was established to review the adverse event profile and efficacy of recombinant human C1 esterase inhibitor (rhC1-INH) for HAE at...

Full description

Bibliographic Details
Main Authors: Anna Valerieva, Maria T. Staevska, Vesna Grivcheva-Panovska, Milos Jesenak, Kinga Viktória Kőhalmi, Katarina Hrubiskova, Andrea Zanichelli, Luca Bellizzi, Anurag Relan, Roman Hakl, Henriette Farkas
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:World Allergy Organization Journal
Subjects:
Angioedema
Hereditary
Complement C1 inhibitor protein
Recombinant human C1 esterase inhibitor
Registry
Ruconest
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455121000296

Internet

http://www.sciencedirect.com/science/article/pii/S1939455121000296

Similar Items